Syneos health, inc. (SYNH)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities:
Net income (loss)

33,574

91,050

58,920

11,292

-30,004

45,670

-10,394

13,560

-24,552

-15,047

-147,998

3,389

21,187

37,491

27,331

30,403

17,405

30,656

37,814

23,321

25,256

-49,780

12,555

15,307

-1,552

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization

56,107

60,379

60,137

60,749

61,200

70,128

68,034

67,502

68,021

83,348

65,432

15,528

15,628

15,559

14,769

14,523

14,353

14,058

13,819

13,893

14,244

14,578

14,331

11,263

14,371

Amortization of Senior Notes premium, net of capitalized loan fees and original issue discount

-

-

-

-

-

-

-

-

-34

-

357

201

201

-

241

262

262

267

267

371

441

882

974

900

2,944

Share-based compensation

15,998

14,329

12,803

13,794

14,267

8,278

9,791

8,375

7,879

8,768

38,880

6,229

5,819

4,616

3,517

3,071

2,816

1,786

1,668

913

707

1,065

881

893

531

Provision for doubtful accounts

271

949

165

-519

1,302

-1,134

-1,719

-1,905

171

2,690

1,319

165

-7

643

829

-31

1,129

296

-295

-356

211

-376

1,275

970

566

Provision for deferred income taxes

8,159

-53,160

4,298

7,249

1,544

961

6,961

3,053

-10,735

1,698

21,814

-9,168

87

-17,034

105

-4,063

-1,268

4,022

395

-1,222

939

7,396

209

-22,955

513

Foreign currency transaction gains

15,019

-17,256

5,133

880

77

1,238

-4,706

25,997

-6,364

-1,648

-382

-3,175

-2,707

-1,892

-5,196

-5,819

-7,774

-1,507

-2,161

2,074

2,389

-3,307

5,756

2,613

2,328

Asset impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,931

0

0

17,245

0

Fair value adjustment of contingent obligations

-4,095

17,831

369

-1,664

724

-15,172

1,194

1,194

1,194

-12,276

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

0

14,750

0

0

-4,355

-239

-1,789

-1,877

-248

-520

-102

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash items

-1,104

-1,589

-30

-1,790

643

320

855

-2,228

-1,796

-3,808

-704

-336

-364

-1,098

-23

-7

-130

-70

-11

47

116

1,241

-157

-222

-9

Changes in operating assets and liabilities:
Accounts receivable, unbilled services, and deferred revenue

53,078

10,306

20,548

64,064

25,471

48,819

-19,827

-21,988

90,617

-21,005

-7,750

15,628

-47,496

40,940

-2,314

229

60,833

-30,034

55,299

807

28,001

12,886

-22,772

46,321

-12,176

Accounts payable and accrued expenses

-66,426

15,979

-19,668

58,687

-26,682

54,653

8,640

10,972

-14,241

-6,850

-18,826

29,151

-20,457

7,552

-4,964

-8,978

13,048

10,271

8,126

3,867

-14,078

7,197

1,576

27,675

-10,705

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-168

6,979

-1,058

-25,253

41,807

12,143

39,803

-8,596

-10,319

49,715

11,942

Other assets and liabilities

15,202

-19,402

16,954

-10,386

13,821

798

-17,852

-9,278

-7,521

41

-11,404

10,651

-2,674

-10,007

-1,116

2,741

-5,596

3,836

5,030

8,672

-2,683

-3,346

1,723

3,115

-2,743

Net cash used in operating activities

-38,607

160,548

74,419

96,820

-13,306

112,448

125,826

112,159

-46,985

88,512

11,320

22,727

75,699

14,366

50,748

45,022

-646

63,618

45,847

51,644

43,631

14,119

36,932

49,186

31,210

Cash flows from investing activities:
Payments associated with business combinations, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,302

Purchases of property and equipment

11,870

13,328

22,579

16,621

11,445

11,632

10,377

11,300

21,286

15,743

12,179

5,403

10,571

14,527

5,336

6,716

4,774

9,546

3,896

2,799

4,870

7,812

4,800

8,315

4,624

Investments in unconsolidated affiliates

6,750

-

6,227

3,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-18,620

-21,789

-28,806

-19,621

-11,445

-11,632

-101,267

-11,300

-21,286

-16,417

-1,690,453

-5,403

-10,571

-14,527

-5,336

-6,716

-4,774

-9,546

-3,896

-2,799

-4,870

-7,812

-4,800

-8,315

-6,926

Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of discount

0

398,805

0

0

183,195

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of debt financing costs

0

43

1,561

848

184

0

-359

3,421

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of long-term debt

0

67,000

114,800

40,000

216,136

36,250

256,896

66,250

31,250

50,000

475,097

0

0

-

-

-

-

0

0

473,938

1,063

158,642

0

0

5,453

Proceeds from accounts receivable financing agreement

6,600

-185

89,800

11,700

26,500

4,100

183,600

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of accounts receivable financing agreement

6,600

0

0

22,400

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from revolving line of credit

300,000

-

-

-

0

-

-

-

-

0

0

0

15,000

0

85,000

15,000

0

-

-

-

-

-

-

-

-

Repayments of revolving line of credit

-

-

-

-

-

-

-

-

-

0

0

15,000

25,000

0

60,000

15,000

30,000

15,000

0

0

0

-

-

-

-

Payments of contingent consideration related to business combinations

26,592

0

170

0

8

23,102

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of finance leases

4,674

5,064

4,752

3,403

1,274

2,759

3,801

4,384

4,479

4,559

3,586

0

0

-

-

-

-

54

57

142

199

225

842

800

813

Payments for repurchases of common stock

32,029

0

7,045

23,055

26,616

0

0

37,492

37,493

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercises of stock options

12,358

647

15,298

4,653

19,724

3,779

10,584

1,790

5,668

2,287

10,797

1,098

5,153

3,476

5,290

5,566

3,559

2,598

1,058

0

0

-

-

-

-

Payments related to tax withholdings for share-based compensation

19,145

632

740

224

11,539

147

829

60

2,323

1,433

4,212

6

1,173

14

788

26

11

33

2,517

644

0

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

125

125

125

Net cash provided by (used in) financing activities

229,918

-91,584

-23,970

-73,577

-26,338

-72,679

-66,983

-109,817

-69,877

-55,880

1,810,176

-13,908

-6,020

3,462

-35,866

5,540

-26,452

-102,015

-1,991

-106,131

-1,262

-59,485

-890

-932

-6,391

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-420

-12,690

305

-4,287

3,078

-6,809

3,309

-6,278

5,127

233

4,195

1,834

2,854

-3,623

1,486

-5,111

42

-3,137

-2,380

-552

-7,603

-6,172

-988

1,451

-706

Net change in cash, cash equivalents, and restricted cash

172,271

34,485

21,948

-665

-48,011

21,328

-39,115

-15,236

-133,021

16,448

135,238

5,250

61,962

-322

11,032

38,735

-31,830

-51,080

37,580

-57,838

29,896

-59,350

30,254

41,390

17,187

Supplemental disclosures of non-cash investing activities:
Purchases of property and equipment included in liabilities

-

-

-

-

-

-

-

-

-

-

-2,404

1,353

1,757

-

-

-

-

-

-

-

-

-

-

-

-

Vehicles acquired through capital lease agreements

-

-

-

-

-

-

-

-

-

-

7,101

0

0

-

-

-

-

-

-

-

-

-

-

-

-